As humans are spreading throughout the world, infectious diseases have been a constant companion such as Bubonic Plague (200 Million deaths), 17th Century Great Plague (3 Million deaths), Plague of Justinian (30-50 Million deaths), etc. Coronavirus Disease (COVID-19) which was published on 11th January 2020 showing the intensity of Global research and development activity to develop a drug/vaccine against the disease. COVID-19 is an infectious disease caused by a newly discovered coronavirus. Human to human transmission has created a pandemic situation across the world. Pharmaceutical companies play a crucial role in this scenario to provide Drugs/Vaccines/Therapies to treat and tackle the novel coronavirus disease of 2019. This paper consists of the Drugs and Vaccines which are developed, or in the process of development, their current stage of development (clinical trials) with their patent review.

Keywords: vaccines, Covid-19, patent


Coronavirus was discovered in the early 1960s. The name of the virus comes from the crown-like spikes it has on its surface while the word “Corona” is derived from the Latin word “crown”. Coronaviruses (CoV) are a large family of viruses that cause illnesses ranging from a common cold to more severe diseases. Novel coronavirus (nCoV) is a new strain that has not been previously ascertained in humans.

Coronavirus is one of the common viruses that can cause infection in your sinuses, nose, or upper throat. Most of the coronaviruses are not dangerous and are present with mild symptoms and are treated easily symptomatically, but it killed 858 people in MERS in 2015 and this was a result of a severe presentation causing respiratory failure [1]. To be more precise, Coronavirus comes under the family of Orthocoronavirinae and is surrounded by an envelope like frame which gives a sense of the single-stranded RNA genome. This document aims at providing an analysis of Drugs/Vaccines/Therapies developed, developing, or under clinical trials to prevent coronavirus disease2019 outbreaks.

For more details: Click here